GBGaurav Vivek Bhalerao

Gaurav Vivek Bhalerao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gaurav Vivek Bhalerao has a total of 98 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diagnose Harmonisation (DHARM): An open-source tool for the harmonisation and analysis of batch effects in MRI-derived measures.

    by Jacob Turnbull, Gaurav Bhalerao, Thomas E. Nichols, Paul McCarthy, Grace Gillis, Jasmine Blane, Brian Zhaoyi Mo, Shaun Warrington, Stamatios N. Sotiropoulos, Renato Besenczi, et al.

    Technical differences between scanners, acquisition protocols, machine hardware and processing pipelines can introduce systematic variation into MRI-derived measures. Numerous harmonisation methods have been developed to reduce these effects. However, validation of these methods is often performed using different criteria depending on the method itself, the datasets used and the study design. Consequently, determining whether harmonisation is required, selecting an appropriate method and establishing whether or not technical variation has been sufficiently removed without compromising biological signal remain challenging. In this manuscript, we introduce Diagnose Harmonisation (DHARM), an open-source Python toolbox for diagnosing batch effects, applying harmonisation and evaluating harmonisation performance in cross-sectional and repeated-measures settings. DHARM is user-friendly, comes with GUI-based and command-line interfaces, and has graphical reporting. It provides standardised reporting workflows combining complementary measures of batch-associated differences in feature location, scale, empirical distributions, covariance and multivariate structure, together with measures assessing preservation of biological covariate effects and repeated-measures consistency. The framework includes several established harmonisation approaches, but its evaluation workflow is method-agnostic: users can also supply data harmonised using external or newly developed methods and benchmark their outputs using the same common set of diagnostics. We demonstrate DHARM using multisite cross-sectional MRI measures from UK Biobank, Cam-CAN and OxBAC as well as travelling-heads data from the ON-Harmony dataset. Across the cross-sectional datasets, harmonisation substantially reduced additive batch effects, while residual differences in variance and empirical distributions varied between methods. Multivariate diagnostics further demonstrated that reduction of batch-associated structure can coexist with preservation or increased detectability of biologically relevant variation. In the repeated-measures example, harmonisation reduced batch-associated and within-subject variability, while broadly preserving subject-level and biological relationships. DHARM provides a reproducible framework for diagnosing batch effects, applying different harmonisation methods and evaluating harmonisation as a multi-criteria problem rather than relying on a single measure of success. By jointly characterising technical variation and preservation of biologically meaningful information, DHARM can support dataset- and objective-specific selection, benchmarking and validation of harmonisation strategies.

  • Open Access

    Tackling Bias in Cortical Thickness Estimation in UK Biobank Using Harmonisation Approaches

    by Jacob Turnbull, Gaurav Bhalerao, Rach Dawson, Frederik Lange, Fidel Alfaro-Almagro, Stephen Smith, Ludovica Griffanti

    Big neuroimaging data enable researchers to study subtle structural and functional brain changes and relationships between brain characteristics and genetics, lifestyle, and disease factors. However, substantial effort is needed to minimise technical, non-biological differences between data batches to avoid incorrect inferences. In this study, we address a previously identified bias in UK Biobank FreeSurfer IDPs derived from only the T1 image compared to those using both T1 and T2-FLAIR by treating the bias as a batch effect and using harmonisation approaches. We investigate and characterise this bias through direct within-participant comparison at the image and IDP level, comparing the results with those seen in the wider UKB sample. We then assess different methods of addressing the effect of missing T2-FLAIR, starting from simple linear regression before moving to ComBat, a widely used harmonisation method, testing different approaches for applying ComBat and showing its similarity to simple linear regression. Finally, we examine how ComBat estimates vary with batch and sample size. Our results show clear benefits in using both T1 and T2-FLAIR data in FreeSurfer, as opposed to just the T1, which is more common, with the pial surface fitting being less likely to fail and showing greater biologically plausible inter-subject variability. This is particularly important for cortical thickness IDPs, where T2-FLAIR omission leads to reduced true variability and systematic underestimation, as shown through within-participant repeat testing. We demonstrate that ComBat can address this bias, with its standard use (i.e., applied separately on different IDP categories) showing the best improvement in cortical thickness measures where the bias is strongest, and we find that it is important not to pool ComBat priors across different classes of IDPs. Our proposed version of ComBat with a reference batch (i.e., estimating mean and variance only from data with T2-FLAIR available) performed best in recovering both mean and variance differences between batches across different IDP classes and offers a promising approach for cases where a reference batch is clearly identifiable. While ComBat reliably corrects mean (additive) batch effects with relatively small sample sizes (≈30 subjects per batch), we show that its variance (multiplicative) correction is substantially less stable, requiring much larger sample sizes and becoming unreliable when batches are small or imbalanced, or when there is a large variance difference between them.

  • Open Access

    Harmonising Structural Brain MRI from Multiple Sites with Limited Sample Sizes

    by Gaurav Vivek Bhalerao, Pawel Markiewicz, Jacob Turnbull, David L. Thomas, Enrico De Vita, Laura Parkes, Gerard Thompson, Jane MacKewn, Georgios Krokos, Catriona Wimberley, et al.

    Harmonisation is widely used to mitigate site- and scanner-related batch variability in multisite neuroimaging studies and is particularly critical in longitudinal clinical trials, where detection of subtle biological or treatment-related changes depends on reliable measurement across scanners and timepoints. However, the effectiveness of harmonisation in small, heterogeneous clinical datasets remains insufficiently understood, particularly in relation to subject-level variability and consistency across acquisition settings, and its impact on both removal of technical variability and preservation of biological variation in pooled multisite analyses. We systematically evaluated a range of image-based and statistical harmonisation methods using a clinically realistic multisite, multiscanner structural T1-weighted (T1w) MRI test-retest dataset comprising three controlled acquisition scenarios: repeatability, intra-scanner reproducibility and inter-scanner reproducibility. Methods were applied under different batch specifications (site, scanner, or both) and performance was assessed within each scenario and in pooled data using a multi-metric framework capturing both technical and biological variability in volumetric imaging-derived phenotypes (IDPs) relevant to aging and dementia research. Across IDPs, before harmonisation variability was lowest in the repeatability scenario (median variability=0.6 to 2.7%, rank consistency ρ ≥0.9), with modest increases under intra-scanner reproducibility (0.5 to 3.2%, ρ=0.5 to 1.0) and substantially greater variability under inter-scanner reproducibility conditions (1.7 to 19.2%, ρ =−0.1 to 0.9). These results offer important information to consider for multisite study design, including sample size calculation in clinical trials. Harmonisation performance was strongly context dependent, with clearer benefits emerged in inter-scanner scenarios where both variability reduction and improvements in subject-level consistency were observed. In pooled data, approaches that explicitly modelled site as batch and accounted for repeated-measure structure showed greater consistency across IDPs in batch effect mitigation and more accurately reflected underlying biological variation. Our evaluation metrics enabled disentangling the removal of global batch effect while highlighting residual variability at the phenotype-specific or multivariate levels. These findings demonstrate that harmonisation cannot be treated as a one-size-fits-all solution and must be interpreted relative to the acquisition context, dataset structure, and downstream analytic goals. Multi-metric evaluation under realistic clinical constraints is essential to support reliable and translatable neuroimaging inference by ensuring appropriate correction of batch effects while preserving longitudinal biological signals and sensitivity to clinically meaningful change in multisite studies.

  • Open Access

    Automated quality control of T1-weighted brain MRI scans for clinical research datasets: methods comparison and design of a quality prediction classifier

    by Gaurav Bhalerao, Grace Gillis, Mohamed Dembele, Sana Suri, Klaus Ebmeier, Johannes Klein, Michele Hu, Clare Mackay, Ludovica Griffanti

    T1-weighted (T1w) MRI is widely used in clinical neuroimaging for studying brain structure and its changes, including those related to neurodegenerative diseases, and as anatomical reference for analysing other modalities. Ensuring high-quality T1w scans is vital as image quality affects reliability of outcome measures. However, visual inspection can be subjective and time consuming, especially with large datasets. The effectiveness of automated quality control (QC) tools for clinical cohorts remains uncertain. In this study, we used T1w scans from elderly participants within ageing and clinical populations to test the accuracy of existing QC tools with respect to visual QC and to establish a new quality prediction framework for clinical research use. Four datasets acquired from multiple scanners and sites were used (N = 2438, 11 sites, 39 scanner manufacturer models, 3 field strengths—1.5T, 3T, 2.9T, patients and controls, average age 71 ± 8 years). All structural T1w scans were processed with two standard automated QC pipelines (MRIQC and CAT12). The agreement of the accept–reject ratings was compared between the automated pipelines and with visual QC. We then designed a quality prediction framework that combines the QC measures from the existing automated tools and is trained on clinical research datasets. We tested the classifier performance using cross-validation on data from all sites together, also examining the performance across diagnostic groups. We then tested the generalisability of our approach when leaving one site out and explored how well our approach generalises to data from a different scanner manufacturer and/or field strength from those used for training, as well as on an unseen new dataset of healthy young participants with movement-related artefacts. Our results show significant agreement between automated QC tools and visual QC (Kappa = 0.30 with MRIQC predictions; Kappa = 0.28 with CAT12’s rating) when considering the entire dataset, but the agreement was highly variable across datasets. Our proposed robust undersampling boost (RUS) classifier achieved 87.7% balanced accuracy on the test data combined from different sites (with 86.6% and 88.3% balanced accuracy on scans from patients and controls, respectively). This classifier was also found to be generalisable on different combinations of training and test datasets (average balanced accuracy of leave-one-site-out = 78.2%; exploratory models on field strengths and manufacturers = 77.7%; movement-related artefact dataset when including 1% scans in the training = 88.5%). While existing QC tools may not be robustly applicable to datasets comprising older adults, they produce quality metrics that can be leveraged to train more robust quality control classifiers for ageing and clinical cohorts.


  • Open Access

    From Big Data to the clinic: methodological and statistical enhancements to implement the UK Biobank imaging framework in a memory clinic

    by Grace Gillis, Gaurav Bhalerao, Jasmine Blane, Robert Mitchell, Pieter M Pretorius, Celeste McCracken, Thomas E Nichols, Stephen M Smith, Karla L Miller, Fidel Alfaro-Almagro, et al.

    Introduction The analysis tools and statistical methods used in large neuroimaging research studies differ from those applied in clinical contexts, making it unclear whether these techniques can be translated to a memory clinic setting. The Oxford Brain Health Clinic (OBHC) was established in 2020 to bridge this gap between research studies and memory clinics. Methods We optimised the UK Biobank imaging framework for the memory clinic setting by integrating enhanced quality control (QC) processes (MRIQC, QUAD, and DSE decomposition) and supplementary dementia-informed analyses (lobar volumes, NBM volumes, WMH classification, PSMD, cortical diffusion MRI metrics, and tract volumes) into the analysis pipeline. We explored associations between resultant imaging-derived phenotypes (IDPs) and clinical phenotypes in the OBHC patient population (N=213), applying hierarchical FDR correction to account for multiple testing. Results 14-24% of scans were flagged by automated QC tools, but upon visual inspection, only 0-2.4% of outputs were excluded. The pipeline successfully generated 5683 IDPs aligned with UK Biobank and 110 IDPs targeted towards dementia-related changes. We replicated established associations and found novel associations between brain metrics and age, cognition, and dementia-related diagnoses. Conclusion The imaging protocol is feasible, acceptable, and yields high-quality data that is usable for both clinical and research purposes. We validated the use of this methodology in a real-world memory clinic population, which demonstrates the potential of this enhanced pipeline to bridge the gap between big data studies and clinical settings. Key Points The imaging methods, analysis techniques, and population characteristics in research studies often differ to those in traditional clinical settings. To bridge this gap, we optimised the UK Biobank imaging framework for memory clinic use by integrating enhanced quality control (QC) and supplementary analyses targeted towards dementia-related changes. We generated 5683 imaging-derived phenotypes (IDPs) aligned with UK Biobank and 110 supplementary dementia-informed IDPs that captured both established and novel associations between brain metrics and dementia-related clinical phenotypes, highlighting the value of integrating UK Biobank-aligned imaging and analyses in a real-world memory clinic population.

  • Open Access

    Automated quality control of T1-weighted brain MRI scans for clinical research: methods comparison and design of a quality prediction classifier

    by Gaurav Bhalerao, Grace Gillis, Mohamed Dembele, Sana Suri, Klaus Ebmeier, Johannes Klein, Michele Hu, Clare Mackay, Ludovica Griffanti

    Introduction: T1-weighted MRI is widely used in clinical neuroimaging for studying brain structure and its changes, including those related to neurodegenerative diseases, and as anatomical reference for analysing other modalities. Ensuring high-quality T1-weighted scans is vital as image quality affects reliability of outcome measures. However, visual inspection can be subjective and time-consuming, especially with large datasets. The effectiveness of automated quality control (QC) tools for clinical cohorts remains uncertain. In this study, we used T1w scans from elderly participants within ageing and clinical populations to test the accuracy of existing QC tools with respect to visual QC and to establish a new quality prediction framework for clinical research use. Methods: Four datasets acquired from multiple scanners and sites were used ( N = 2438, 11 sites, 39 scanner manufacturer models, 3 field strengths – 1.5T, 3T, 2.9T, patients and controls, average age 71 ± 8 years). All structural T1w scans were processed with two standard automated QC pipelines (MRIQC and CAT12). The agreement of the accept-reject ratings was compared between the automated pipelines and with visual QC. We then designed a quality prediction framework that combines the QC measures from the existing automated tools and is trained on clinical datasets. We tested the classifier performance using cross-validation on data from all sites together, also examining the performance across diagnostic groups. We then tested the generalisability of our approach when leaving one site out and explored how well our approach generalises to data from a different scanner manufacturer and/or field strength from those used for training. Results: Our results show significant agreement between automated QC tools and visual QC (Kappa=0.30 with MRIQC predictions; Kappa=0.28 with CAT12’s rating) when considering the entire dataset, but the agreement was highly variable across datasets. Our proposed robust undersampling boost (RUS) classifier achieved 87.7% balanced accuracy on the test data combined from different sites (with 86.6% and 88.3% balanced accuracy on scans from patients and controls respectively). This classifier was also found to be generalisable on different combinations of training and test datasets (leave-one-site-out = 78.2% average balanced accuracy; exploratory models = 77.7% average balanced accuracy). Conclusion: While existing QC tools may not be robustly applicable to datasets comprised of older adults who have a higher rate of atrophy, they produce quality metrics that can be leveraged to train a more robust quality control classifiers for ageing and clinical cohorts.


  • Open Access

    Sample size requirement for achieving multisite harmonization using structural brain MRI features

    by Pravesh Parekh, Gaurav Vivek Bhalerao, Biju Viswanath, Naren P. Rao, Janardhanan C. Narayanaswamy, Palanimuthu T. Sivakumar, Arun Kandasamy, Muralidharan Kesavan, Urvakhsh Meherwan Mehta, Odity Mukherjee, et al.


  • Systematic evaluation of the impact of defacing on quality and volumetric assessments on T1-weighted MR-images

    by Gaurav Vivek Bhalerao, Pravesh Parekh, Jitender Saini, Ganesan Venkatasubramanian, John P. John, Biju Viswanath, Naren P. Rao, Janardhanan C. Narayanaswamy, Palanimuthu T. Sivakumar, Arun Kandasamy, et al.


  • Comparison of electric field modeling pipelines for transcranial direct current stimulation

    by Gaurav V. Bhalerao, Vanteemar S. Sreeraj, Anushree Bose, Janardhanan C. Narayanaswamy, Ganesan Venkatasubramanian


  • Open Access

    Protocol for magnetic resonance imaging acquisition, quality assurance, and quality check for the Accelerator program for Discovery in Brain disorders using Stem cells

    by Pravesh Parekh, Gaurav V. Bhalerao, Rashmi Rao, Vanteemar S. Sreeraj, Bharath Holla, Jitender Saini, Ganesan Venkatasubramanian, John P. John, Sanjeev Jain, ADBS Consortium

    Objective: The Accelerator program for Discovery in Brain disorders using Stem cells (ADBS) is a longitudinal study on five cohorts of patients with major psychiatric disorders from genetically high‐risk families, their unaffected first‐degree relatives, and healthy subjects. We describe the ADBS protocols for acquisition, quality assurance (QA), and quality check (QC) for multimodal magnetic resonance brain imaging studies.Methods: We describe the acquisition and QC protocols for structural, functional, and diffusion images. For QA, we acquire proton density and functional images on phantoms, along with repeated scans on human volunteer. We describe the analysis of phantom data and test–retest reliability of volumetric and diffusion measures.Results: Analysis of acquired phantom data shows linearity of proton density signal with increasing proton fraction, and an overall stability of various spatial and temporal QA measures. Examination of dice coefficient and statistical analyses of coefficient of variation in test–retest data on the human volunteer showed consistency of volumetric and diffusivity measures at whole‐brain, regional, and voxel‐level.Conclusion: The described acquisition and QA–QC procedures can yield consistent and reliable quantitative measures. It is expected that this longitudinal neuroimaging dataset will, upon its release, serve the scientific community well and pave the way for interesting discoveries.